Nanomedicine breakthroughs overcoming pancreatic cancer drug resistance through precision nano-interventions
Nanoscale Advances · 2025 · 7 (19) · 5888-5904
DOI: 10.1039/d5na00513b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale Advances, 2025. Verfasst von Linjia Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Afffliated Hospital of Henan University No. 357, Ximen Street Kaifeng 475004 China dxcui@sjtu.edu.cn. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Stimuli-responsive nanocarriers tailored to bypass efflux pumps, target cancer stem cells, and remodel the stroma overcome PDAC resistance and enhance therapeutic efficacy.
Autor:innen und Institutionen
- The First Afffliated Hospital of Henan University No. 357, Ximen Street Kaifeng 475004 China dxcui@sjtu.edu.cn.
ORCID-Profile: Yanfeng Liang, Daxiang Cui
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Peng, L., Liang, Y., Guo, X., Zhang, Q., Gao, Z., Kong, X., Zhang, H., Zhu, B., & Cui, D. (2025). Nanomedicine breakthroughs overcoming pancreatic cancer drug resistance through precision nano-interventions. Nanoscale Advances, 7(19), 5888-5904. https://doi.org/10.1039/d5na00513b
Vancouver
Peng L, Liang Y, Guo X, Zhang Q, Gao Z, Kong X, et al. Nanomedicine breakthroughs overcoming pancreatic cancer drug resistance through precision nano-interventions. Nanoscale Advances. 2025;7(19):5888-5904. doi:10.1039/d5na00513b
BibTeX
@article{Peng2025,
author = {Peng, Linjia and Liang, Yanfeng and Guo, Xiaonan and Zhang, Qiuli and Gao, Zixuan and Kong, Xinxin and Zhang, Haiting and Zhu, Binyu and Cui, Daxiang},
title = {Nanomedicine breakthroughs overcoming pancreatic cancer drug resistance through precision nano-interventions},
journal = {Nanoscale Advances},
year = {2025},
volume = {7},
number = {19},
pages = {5888--5904},
doi = {10.1039/d5na00513b}
}
EUVIMED